National Comprehensive Cancer Network collaborates with Pfizer Global Medical Grants

Jul 1, 2020

The National Comprehensive Cancer Network (NCCN) announced it will collaborate with Pfizer Global Medical Grants to offer grants in support of the adoption of biosimilars in oncology. The NCCN has asked applicants to submit Letters of Intent which describe ‘concepts that develop and validate enduring approaches to improve the safe, effective and efficient adoption of biosimilars in oncology‘.

Print Page Mail Article